Medicare Enrolled
Dr. Philip Berman, MD FACC
Cardiovascular Disease · Houston, TX
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berman
Dr. Philip Berman is a cardiovascular disease specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Berman performed 4,750 Medicare services across 3,523 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berman received a total of $42,993 from 55 pharmaceutical and/or device companies across 803 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in TX
$42,993 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,750
Medicare services
Top 18% in TX for cardiovascular disease
3,523
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~250 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,132 | $92 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
833 | $10 | $80 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
629 | $7 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
508 | $67 | $200 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
425 | $151 | $800 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
206 | $44 | $90 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
117 | $80 | $464 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
114 | $351 | $2,200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
100 | $96 | $315 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
87 | $48 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $126 | $275 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
86 | $144 | $550 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
58 | $197 | $900 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
55 | $10 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
46 | $102 | $300 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
43 | $83 | $200 |
| Cardiac catheterization | 41 | $218 | $2,200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
38 | $136 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $64 | $264 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
33 | $14 | $100 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
23 | $24 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $132 | $293 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 18 | $223 | $2,500 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $42 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.4% high complexity
12.8% medium
75.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$42,993
Total received (2018-2024)
Avg $6,142/year across 7 years
Top 12% in TX for cardiovascular disease
55
Companies
803
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,579 (57.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,414 (42.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,811
2023
$3,336
2022
$6,327
2021
$14,226
2020
$9,223
2019
$2,396
2018
$2,674
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$24,735
Janssen Pharmaceuticals, Inc
$2,892
CVRx, Inc.
$2,136
Novartis Pharmaceuticals Corporation
$1,748
Amgen Inc.
$1,560
Abbott Laboratories
$1,126
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,088
Boston Scientific Corporation
$603
E.R. Squibb & Sons, L.L.C.
$601
ABIOMED
$523
Medtronic, Inc.
$466
ShockWave Medical, Inc
$458
Merck Sharp & Dohme LLC
$401
Edwards Lifesciences Corporation
$357
Amarin Pharma Inc.
$332
Impulse Dynamics (USA) Inc.
$315
ATRICURE, INC.
$285
SANOFI-AVENTIS U.S. LLC
$261
Esperion Therapeutics, Inc.
$253
BIOTRONIK INC.
$218
PFIZER INC.
$211
Gilead Sciences, Inc.
$194
Regeneron Healthcare Solutions, Inc.
$158
Lexicon Pharmaceuticals, Inc.
$157
Chiesi USA, Inc.
$153
Actelion Pharmaceuticals US, Inc.
$136
Cardiovascular Systems Inc.
$135
Merck Sharp & Dohme Corporation
$133
ARBOR PHARMACEUTICALS, INC.
$128
Medtronic Vascular, Inc.
$119
Melinta Therapeutics, Inc.
$117
Philips North America LLC
$112
iRhythm Technologies, Inc.
$106
BOSTON SCIENTIFIC CORPORATION
$105
HeartFlow, Inc.
$98
Bardy Diagnostics, Inc.
$93
Novo Nordisk Inc
$60
SCPHARMACEUTICALS INC.
$49
ARALEZ PHARMACEUTICALS US INC.
$39
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$37
HEARTFLOW, INC.
$33
Allergan Inc.
$30
Argentum Medical
$26
GE Healthcare
$23
Astellas Pharma US Inc
$23
Philips Electronics North America Corporation
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
Alnylam Pharmaceuticals Inc.
$19
Noden Pharma USA Inc
$18
Preventice Services, LLC
$18
Ethicon US, LLC
$17
Lilly USA, LLC
$16
Tactile Systems Technology Inc
$13
Coala Life Inc
$10
ZOLL Circulation Inc
$8
Top 3 companies account for 69.2% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (BH4) IGT Devices Undivided · ATRICLIP LAA EXCLUSION SYSTEM · Accent Pacemaker · Assurity Pacemaker · Azure · BG Mini Plus · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CRT-Ds · Carnation Ambulatory Monitor · Coala Heart Monitor · Confirm Rx · Corlanor · DERMABOND Portfolio · Diamondback Coronary · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · FARXIGA · FFRct · FUROSCIX · Flexitouch Plus · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · ILAB · INVOKANA · Impella · Inpefa · JANUVIA · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MOUNJARO · MULTAQ · Mitra Clip system · MitraClip System · NA · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · Optimizer · Orsiro Mission · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESOLUTE ONYX · Repatha · Resolute · Reveal LINQ · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEKTURNA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TherOx DS2 Console · VENASEAL · VERQUVO · VIGILANT · Vabomere · Vascepa · Verquvo · Victoza · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch · ZONTIVITY · Zio monitor · iLab Ultrasound Imaging System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $905 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
392
Per 100K population
8.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Berman is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 18% in TX), with speaking/promotional industry engagement in the top 12% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Berman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Berman performed 1,132 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berman receive payments from pharmaceutical companies?
Yes. Dr. Berman received a total of $42,993 from 55 companies across 803 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berman's costs compare to other cardiologists in Houston?
Dr. Berman's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Houston
Browse cardiologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
CVRx, Inc. Payments to Doctors
See all physicians who received payments from CVRx, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology